| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 01/18/2011 | US7872120 Methods for synthesizing a collection of partially identical polynucleotides |
| 01/18/2011 | US7872119 Antisense strand, sense strand are non-phosphorylated at the 5' and 3' termini; pulmonary, eye, microvascular, hearing disorders; target for hypoxia-inducible factor-1 that may regulate hypoxia-induced pathogenesis independent of growth factors such as VEGF |
| 01/18/2011 | US7872118 siRNA and methods of manufacture |
| 01/18/2011 | US7872117 c-met siRNA adenovirus vectors inhibit cancer cell growth, invasion and tumorigenicity |
| 01/18/2011 | US7872116 Oligonucleotide primer for use in screening for microorganismal infection |
| 01/18/2011 | US7872115 hybrid polynucleotide comprising a S.cerevisiae YIL066W-A Promoter operably linked to a reporter; used in assays to identify novel anti-fungal and anti-cancer substances; drug screening |
| 01/18/2011 | US7872113 Nucleic acids encoding antibodies that bind interleukin-4 receptor |
| 01/18/2011 | US7872112 comprising rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A),deoxyhypusine synthase (DHS) nucleic acids and polypeptides; human cytomegalovirus immediate-early promoter/enhancer |
| 01/18/2011 | US7872111 Process for producing protein with reduction of acidic sugar chain and glycoprotein produced thereby |
| 01/18/2011 | US7872100 Nitrile hydratases from metagenome libraries |
| 01/18/2011 | US7871986 provides a prostate specific antigen oligo-epitope peptide (PSA-OP) that is useful as an immunogen in the prevention or treatment of prostatic cancer and in the inhibition of prostatic cancer cells and in the establishment and characterization of PSA-specific cytotoxic T-cell lines |
| 01/18/2011 | US7871985 Compositions and methods for inhibiting expression of factor VII gene |
| 01/18/2011 | US7871984 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis |
| 01/18/2011 | US7871819 recombinant vector comprising a sequence encoding a heterologous polypeptide inserted between E4 and E3 transcription units of an ovine adenovirus genome; directing expression of a coding sequence in a cell; cancer |
| 01/18/2011 | US7871817 in vitro method for producing a T-cell expressing a T-cell receptor (TCR); mediate an oncogen-specific T-cell response |
| 01/18/2011 | US7871815 producing a protein by cloning an open reading frame encoding a protein into the nucleic acid sequence of SEQ ID 151, introducing the resulting nucleic acid sequence into a host cell and exposing the host cell to rhamnose, thereby inducing expression of the protein |
| 01/18/2011 | US7871806 Asparaginases |
| 01/18/2011 | US7871804 Method for producing polyunsaturated long-chain fatty acids in transgenic organisms |
| 01/18/2011 | US7871801 L-amino acid-producing bacterium and a method for producing L-amino acids |
| 01/18/2011 | US7871799 preselecting via computational techniques; high speed hybridization; bioinformatics |
| 01/18/2011 | US7871798 Mammalian cells that express VEGF-D polypeptides |
| 01/18/2011 | US7871796 Isolation of binding proteins with high affinity to ligands |
| 01/18/2011 | US7871795 Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins |
| 01/18/2011 | US7871780 Genomic markers of hepatitis B virus associated with hepatocellular carcinoma |
| 01/18/2011 | US7871779 Molecular identification of Aspergillus species |
| 01/18/2011 | US7871777 complementary hybridization; fluorophores; semiconductors |
| 01/18/2011 | US7871771 Method for nucleic acid analysis |
| 01/18/2011 | US7871770 photoresists; digitally coded, transmissive and opaque to light, bar code imaging; for high throughput bioanalysis; point mutations in DNA and RNA |
| 01/18/2011 | US7871769 Using variation in tumor marker expression as diagnostic/prognostic indicator of antitumor agent efficacy; gene expression profiling and metastasis |
| 01/18/2011 | US7871768 detecting point mutations, deletions |
| 01/18/2011 | US7871767 Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic applications |
| 01/18/2011 | US7871764 extracting by applying sample to silica column, treating with protease, incubating, centrifuging, transferring to ethanol solution, washing, adding buffer, centrifuging with magnesium chloride, |
| 01/18/2011 | US7871763 gene expression; probes, primers, antibodies |
| 01/18/2011 | US7871615 Humanized antibodies that recognize beta amyloid peptide |
| 01/18/2011 | US7871607 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant soluble neutral active Hyaluronidase Glycoproteins to enhance stability and serum pharmacokinetics over natural slaughterhouse enzymes; transgenic animals; dosage forms |
| 01/18/2011 | CA2511128C Late-pcr |
| 01/18/2011 | CA2455145C Pregnancy-related serine protease |
| 01/18/2011 | CA2333987C Compounds and methods for detecting biomolecules |
| 01/18/2011 | CA2284399C Use of magnesium (mg2+) for the preparation of a therapeutic composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy |
| 01/18/2011 | CA2156976C Genetic sequences encoding glucocorticoid dehydrogenases and uses therefor |
| 01/13/2011 | WO2011005861A1 Oligonucleotide end caps |
| 01/13/2011 | WO2011005793A1 Cell-based bioprocessing |
| 01/13/2011 | WO2011005595A2 2-5a analogs and their methods of use |
| 01/13/2011 | WO2011005273A1 Tivozanib response prediction |
| 01/13/2011 | WO2011004994A2 A novel genome walking method for cloning of unknown dna sequences adjacent to known sequence |
| 01/13/2011 | WO2011004361A2 Long-acting coagulation factors and methods of producing same |
| 01/13/2011 | WO2011003184A1 Detection of microcystin-producing cyanobacteria |
| 01/13/2011 | WO2010135588A3 Phytases, nucleic acids encoding them and methods for making and using them |
| 01/13/2011 | WO2010135411A3 Aurora-a copy number and sensitivity to inhibitors |
| 01/13/2011 | WO2010123982A3 Gene expression signatures associated with resistance to imatinib mesylate |
| 01/13/2011 | WO2010107740A3 Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1 |
| 01/13/2011 | WO2010107733A3 Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2 |
| 01/13/2011 | WO2010096201A3 Synthesis of ara-2'-o-methyl-nucleosides, corresponding phosphoramidites and oligonucleotides incorporating novel modifications for biological application in therapeutics, diagnostics, g- tetrad forming oligonucleotides and aptamers |
| 01/13/2011 | US20110010805 improved ability to enzymatically degrade lignocellulosic feedstocks; fermentation |
| 01/13/2011 | US20110010804 Genes that increase plant oil and method for using the same |
| 01/13/2011 | US20110010803 Polypeptides, Such As Lipases, Capable Of Altering The Seed Storage Content In Transgenic Plants |
| 01/13/2011 | US20110010801 Maize cystatin promoter for pericarp preferred expression |
| 01/13/2011 | US20110010800 Plants with increased yield |
| 01/13/2011 | US20110010799 Floral Transition Genes in Maize and Uses Thereof |
| 01/13/2011 | US20110010798 Drought tolerant plants and related constructs and methods involving gene encoding ferrochelatases |
| 01/13/2011 | US20110010797 Method for changing nitrogen utilization efficiency in plants |
| 01/13/2011 | US20110010795 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use |
| 01/13/2011 | US20110010793 Methods and Compositions for Increased Yield |
| 01/13/2011 | US20110010785 Products and their use for the diagnosis, prevention and/or care of human and/or animal pathologies characterised by the anomalous deposition of b-amyloid and/or amyloid-like substance in human and/or animal organs and tissues, and screening method for determining the risk of such pathologies |
| 01/13/2011 | US20110010784 Insulin-like gene of prawns and uses thereof |
| 01/13/2011 | US20110010102 Methods and Systems for Sequence-Directed Molecular Breeding |
| 01/13/2011 | US20110009655 Novel atp:citrate lyase genes |
| 01/13/2011 | US20110009608 Automatic refining apparatus, multi-well plate kit and method for extracting hexane from biological samples |
| 01/13/2011 | US20110009607 Method for preparing dna fragment having sticky end |
| 01/13/2011 | US20110009606 Synthesis of 2',3' - and 3',5' -cyclic phosphate mono-and oligonucleotides |
| 01/13/2011 | US20110009603 Method and composition for crystallizing G protein-coupled receptors |
| 01/13/2011 | US20110009476 Transcription factor decoys, compositions and methods |
| 01/13/2011 | US20110009471 Oligonucleotide analogues and methods utilizing the same |
| 01/13/2011 | US20110009468 Mirna, sirna and use thereof in therapy |
| 01/13/2011 | US20110009412 Macrophage migration inhibitory factor antagonists and methods of using same |
| 01/13/2011 | US20110009353 Targeting cdk4 and cdk6 in cancer therapy |
| 01/13/2011 | US20110009329 Method for treating neurodegenerative diseases |
| 01/13/2011 | US20110009328 Polypeptide Derivatives of Parathyroid Hormone (PTH) |
| 01/13/2011 | US20110009312 Albumin Fusion Proteins |
| 01/13/2011 | US20110009292 Attachment of molecules to surfaces |
| 01/13/2011 | US20110009281 Methods for creating and identifying functional rna interference elements |
| 01/13/2011 | US20110009277 Method for methylation analysis |
| 01/13/2011 | US20110009275 Methods of amplifying and sequencing nucleic acids |
| 01/13/2011 | US20110008914 Biomarkers for the Diagnosis and Treatment of Pancreatic Cancer |
| 01/13/2011 | US20110008885 Linear double-stranded rna molecule interfering with different target genes |
| 01/13/2011 | US20110008882 SPECIFIC GRP78 EXPRESSION-INHIBITION RNAi SEQUENCE, MEDICINE THEREOF AND METHOD THEREOF |
| 01/13/2011 | US20110008870 Fungal protease and use thereof |
| 01/13/2011 | US20110008860 Genes encoding key catalyzing mechanisms for ethanol production from syngas fermentation |
| 01/13/2011 | US20110008849 Novel lactose phosphorylase enzymes |
| 01/13/2011 | US20110008845 Primers for pcr amplification comprising a basic parts within the primer sequences |
| 01/13/2011 | US20110008842 Novel chimeric tnf ligands |
| 01/13/2011 | US20110008841 Polynucleotides encoding il-17 receptor a antigen binding proteins |
| 01/13/2011 | US20110008840 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same |
| 01/13/2011 | US20110008837 Modifying glycoprotein production in plans |
| 01/13/2011 | US20110008835 System for the heterologous expression of a viral protein in a ciliate host cell |
| 01/13/2011 | US20110008834 Polynucleotides encoding antibodies directed against amyloid-beta peptide |
| 01/13/2011 | US20110008829 Use of Synthetic Scaffolds for the Production of Biosynthetic Pathway Products |
| 01/13/2011 | US20110008828 Methods of incorporating amino acid analogs into proteins |
| 01/13/2011 | US20110008827 Method to produce recombinant MBP8298 and other polypeptides by nucleotide structure optimization |
| 01/13/2011 | US20110008808 Biomarkers |